AUPH
Aurinia Pharmaceuticals Inc
16.70$
+0.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 64.1% | 49.3% | 72.7% | 92.3% | 91.1% | 97.2% | 90.5% | 94.5% | 94.0% | 77.5% | 81.1% | 65.5% | |
| 43.4% | 17.1% | 69.6% | 87.2% | 80.9% | 94.4% | 58.7% | 42.7% | 20.0% | 8.9% | 15.2% | 10.7% | |
| 62.4% | 46.9% | 69.6% | 91.4% | 86.3% | 94.4% | 85.9% | 85.8% | 82.7% | 64.0% | 65.1% | 53.0% | |
| 0.2% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | 2.8% | 2.9% | 4.4% | 6.6% | 5.5% | |
| – | – | 0.0% | -0.1% | – | – | 3.0% | 3.6% | 5.3% | 7.2% | 7.1% | 6.1% | |
| 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 1.0% | 1.8% | 1.8% | – | – | – | |
| 35.3% | 50.6% | 27.3% | 7.4% | 8.6% | 2.7% | 2.0% | 1.5% | 1.4% | 0.9% | 0.8% | 0.5% | |
| 13.9% | 40.5% | 36.9% | 12.7% | 22.8% | 7.9% | 12.1% | 11.8% | 13.9% | 31.0% | 31.4% | 22.7% | |
| 5.4% | 10.8% | 13.9% | 4.3% | 5.0% | 3.5% | 6.9% | 7.5% | 9.8% | 14.1% | 17.8% | 12.5% | |
| – | – | 5.1% | 2.1% | 0.1% | 2.1% | 0.2% | 0.2% | 0.2% | 2.8% | 2.7% | 2.3% | |
| 2.7% | 6.2% | 5.0% | 2.0% | 4.8% | 1.3% | 0.6% | 0.7% | 0.7% | 0.8% | 0.9% | 0.4% | |
| 21.4% | 16.4% | 16.0% | 6.2% | – | – | – | – | – | – | – | – | |
| 86.1% | 59.5% | 63.1% | 87.3% | 77.2% | 92.1% | 87.9% | 88.2% | 86.1% | 69.0% | 68.6% | 77.3% | |
| -451.3% | -767.9% | -493.1% | -185.3% | -285.2% | -145.7% | -124.0% | -139.2% | -183.6% | -171.9% | -170.1% | -86.4% | |
| 55.7% | 95.8% | 61.9% | 40.5% | 58.1% | 28.7% | 25.6% | 23.8% | 30.1% | 26.1% | 26.5% | 18.5% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.